SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-119234
Filing Date
2014-03-28
Accepted
2014-03-27 21:12:10
Documents
9
Period of Report
2014-05-22
Effectiveness Date
2014-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d689411ddef14a.htm DEF 14A 1390255
2 GRAPHIC g689411g12c39.jpg GRAPHIC 9412
3 GRAPHIC g689411g23e48.jpg GRAPHIC 2694
4 GRAPHIC g689411g24m87.jpg GRAPHIC 7812
5 GRAPHIC g689411g59k96.jpg GRAPHIC 3044
6 GRAPHIC g689411g62e24.jpg GRAPHIC 3041
7 GRAPHIC g689411g69c47.jpg GRAPHIC 17108
8 GRAPHIC g689411g81w06.jpg GRAPHIC 2806
9 GRAPHIC g689411g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-14-119234.txt   1465493
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 14723063
SIC: 2834 Pharmaceutical Preparations